InMode Ends Sale Talks: No Good Offers Found
InMode has stopped its review of buyout or merger proposals after deciding none were good enough for shareholders.
Already have an account? Sign in.
InMode has stopped its review of buyout or merger proposals after deciding none were good enough for shareholders.
AST SpaceMobile got approval to beam cell service from space, boosting coverage everywhere using normal phones—no special device needed.
Axe Compute (AGPU) stock jumped after a $260M deal to build a private AI cluster, showing big companies want dedicated GPU power over shared cloud.
Inhibrx is drawing strong interest from Merck and other big pharma for its experimental cancer drug INBRX-106 that could boost Keytruda. Potential $9B spin-off value.